| NDC Code | 57894-505-05 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 57894-505 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Darzalex Iv |
|---|
| Non-Proprietary Name | Daratumumab |
|---|
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20211015 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761036 |
|---|
| Manufacturer | Janssen Biotech, Inc. |
|---|
| Substance Name | DARATUMUMAB |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/5mL |
|---|
| Pharmacy Classes | Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC] |
|---|